logo
Osteopetrosis—More than only a disease of the bone
Iron overload and chronically transfused patients: Numbers, scales, and clinical research
A single-center experience in 20 patients with infantile malignant osteopetrosis
Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant
An age-adapted approach for the use of D-dimers in the exclusion of deep venous thrombosis
Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene ( Kel )
Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation
Genome-wide association studies and the genetic dissection of complex traits
Russell bodies and Mott cells
Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia
BCR-ABL1 REAL-TIME QUANTIFICATION IN PATIENTS WITH CML SUMMARY TABLE
Petechial bleeding after sunburn in a patient with mild thrombocytopenia
Sequential evaluation of serum hepcidin in anemic myeloma patients: Study of correlations with myeloma treatment, disease variables, and anemia response
DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: Is the risk reduction due to intracellular folate unbalancing?
Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea
FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype
Overexpression of nucleolin in engrafted acute myelogenous leukemia cells
Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531)
Hemoglobin lansing: A novel hemoglobin variant causing falsely decreased oxygen saturation by pulse oximetry
Endothelial tissue factor expression in the transgenic sickle mouse is stimulated by inflammation and modulated by nitric oxide: A role for both endothelial cell and peripheral blood monocyte
The Roles and Effectiveness of Water In Sickle Cell Management
A Model for Microvascular Hemodynamics and Oxygenation Measurements in Experimental Sickle Cell Disease
The Influence of Sleep on Pain in Children with Sickle Cell Disease
Character of Pulmonary Vein Tissue Factor Positivity in Sickle Transgenic Mice
Sickle red blood cells have increased phosphorylation of adducin and increased ROS production mediated by signaling pathways involving Rac GTPases.
Hydroxyurea Treatment Effects in a Sickle Cell Mouse Model
Pain in Sickle Cell Disease: Characterization and molecular mechanisms in a mouse model.
Novel Genetic Modifiers of the Severity of Sickle Cell Anemia Identified Through A Genome-Wide Association Study
Cyclical Changes in Erythrocyte Characteristics during Chronic Transfusion Therapy in Pediatric Sickle Cell Patients
Genetic Correction of Sickle Cell Anemia: Critical Determinants for Successful Correction
Intravascular Hemolysis in Sickle Cell Disease: Discovery of Associated Genomic Copy Number Variations.
POMALIDOMIDE AUGMENTS ERYTHROPOIESIS AND FETAL HEMOGLOBIN PRODUCTION IN A HUMANIZED MOUSE MODEL OF SICKLE CELL DISEASE
Placenta growth factor released from erythroid cells contributes to both asthma and airway hyper reactivity via increased production of leukotrienes in Sickle Cell Disease (SCD)
Structural Interactions of KC1 Cotransport Proteins KCC1 and KCC3 in Sickle and Normal Erythrocyte Membranes Have Potential Functional Implications.
Sickle Cell Mice with Hypoxia-Reoxygenation Have Oxidative and Inflammatory Liver Injury - toward a New Experimental Model for Vaso-Occlusive Injury
The HDAC inhibitor trichostatin A exhibits multiple modalities of benefit for the vascular pathobiology of sickle disease: A true single-agent, multi-modality therapy for vasculopathy
Site-specific Duplication of a Defined 3′UTR Motif Increases the Stability of β-globin mRNAs
Site-specific Duplication of a Defined 3′UTR Motif Increases the Stability of β-globin mRNAs
Mechanism of Reduction in Titers from Lentivirus Vectors Carrying Chromatin Insulator Elements in the 3′ LTR
Previous Interpersonal Experiences with Health Care and Sickle Cell Patient Trust
Pulmonary Hypertension and Vascular Disease in Patients with Sickle Cell Anemia on Chronic Transfusion Therapy
Placenta growth factor elaborated from erythroid cells likely contributes to hypercoagulable state in SCD via activation of plasminogen activator inhibitor-1.
Placenta growth factor released from erythroid cells contributes to both asthma and airway hyper reactivity via increased production of leukotrienes in Sickle Cell Disease (SCD)
Microalbuminuria as a marker of nephropathy in sickle cell disease: correlation with fetal hemoglobin and uric acid
Efficacy and safety of endothelin receptor antagonists for Pulmonary Hypertension in adult patients with Sickle Cell Disease.
Allosensitization in sickle cell patients receiving multiple blood transfusions
Clinical Pharmacogenetics and Analgesic Therapeutics for Sickle Cell Disease Pain Management: A Structured Review
Changes in Plasma Endothelin-1 Levels and Platelet-Endothelial Cell Adhesion Molecule-1 (PECAM-1) During Acute Pain in Patients with Sickle Cell Disease.
Title: Preimplantation Genetic Diagnosis (PGD) For Sickle Cell Disease With HLA-Matching For a Sibling Donor
Prevalence of Anxiety and Depressive disorders and symptoms in Adolescents with Sickle Cell Disease: A Pilot Study.
Sickle Cell Patient Hospitalization Patterns & Healthcare Costs during the Transition from Pediatric to Adult Care
Compliance with antibiotic prophylaxis in children with sickle cell anemia: a prospective study
Obstetrical Outcomes of Pregnancies Complicated by Sickle Crisis
BACTERAEMIA IN CHILDREN WITH SICKLE CELL DISEASE: INDIAN SCENARIO.
DEVELOPMENT AND EVALUATION OF A TOOL TO IMPROVE THE QUALITY OF SERVICE PROVIDED TO SICKLE CELL DISEASE PATIENTS AT HEMORIO
DISCLOSURE PROJECT FOR AWARENESS OF PAIN IN HEALTHCARE TREATMENT
EVALUATION OF THE USE OF HYDROXYUREA IN PAIN CRISIS OF SICKLE CELL DISEASE AT HEMORIO
NO-PAIN HOSPITAL: 6th VITAL SIGN - PULSE OXIMETRY. IT'S IMPORTANCE IN ACUTE CHEST SYNDROME (ACS)
USE OF INTRAVENOUS KETOROLAC IN EMERGENCY ROOM PAIN MANAGEMENT PROTOCOL FOR PATIENTS WITH SICKLE CELL DISEASE
Increased Recurrent Biliary Tract Obstruction in Sickle Cell Disease
Early Findings from SCD-PLANE (Sickle Cell Disease Program for Learning and Neuropsychological Evaluation, Children's Hospitals and Clinics of Minnesota): Executive Function Varies with RBC Values in Children with Sickle Cell Disease.
A Global Prediction Model for Hepatic Iron Concentration Measurements Using R2*-MRI
DESCRIPTION OF FOUR KIDNEY TRANSPLANT PATIENTS WITH SICKLE CELL ANEMIA
GLOMERULOPATHY IN SICKLE CELL ANEMIA: CLINICAL COURSE AND ASPECTS OF RENAL HISTOPATHOLOGY
Pharmaco- economics of the Sickle cell Disease in Gwagwalada,Abuja,Nigeria
Spleen Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial
The 3′ end of the Chicken hypersensitive site-4 Insulator has Properties Similar to the 5′ Insulator Core, and is Necessary in Conjunction with the Core for Full Insulator Activity
6R-BH4: Novel Therapy for Endothelial Dysfunction in Sickle Cell Disease
Sickle Cell-Directed Therapy With or Without Angiotensin Blockade Improves Sickle Cell Nephropathy
Abdominal Ultrasound Findings in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial
Laboratory Confirmed Influenza Infections in Sickle Cell Disease
Teenager Transition Tour Program for Young Adults with Sickle Cell Disease
Safety of Combined Chelation Therapy with Deferasirox and Deferoxamine in Transfusion Dependent Thalassemia -Preliminary Results after a Median of 19 Weeks Follow-up.
AN EVALUATION OF THE EFFECTIVENESS OF IBUPROFEN AND MORPHINE FOR ACUTE PAIN IN SICKLE CELL DISEASE: (SWIM TRIAL)
Prolonged QTc in Patients with Sickle Cell Disease (SCD)
Cardiac involvement in childhood sickle cell disease: is it dysfunction or adaptation?
Evaluations of Possible Unique Radiographic Features of Vitamin D Deficiency in Sickle Cell Disease (SCD) patients.
CLINICAL VARIABILITY IN TWIN AND SIBLINGS WITH SICKLE CELL DIESEASE IN GHANA
Inflammatory Biomarker CRP levels at baseline are associated with Hospitalizations for Childhood Sickle Cell Vaso-Occlusive Crises
Hematopoietic stem cell transplant following reduced intensity conditioning: a therapeutic option for adults with severe sickle cell disease?
Effect of Geography and Climate on Pain Frequency in Patients Enrolled in the Muticenter Study of Hydroxyurea in Sickle Cell Anemia
To start with what is priapism ?
Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy (walk-PHaSST): Background, Rationale, Study Design, Current Enrollment and Baseline Data
BACTERAEMIA IN CHILDREN WITH SICKLE CELL DISEASE: INDIAN SCENARIO.
Deferasirox (Exjade®), the Once-daily Oral Iron Chelator, Demonstrates Safety and Efficacy in Patients with Sickle Cell Disease (SCD): 3.5-year Follow-up
EPIDEMIOLOGICAL PROFILE OF SICKLE CELL PATIENTS BEING TREATED WITH HYDROXYUREA AT HEMORIO - FIVE-YEAR FOLLOW-UP
Creating Sibling Donors for Hematopoietic Cell Transplantation in Sickle Cell Disease: A Study of Patient and Caregiver Views
Changes in Plasma Endothelin-1 Levels and Platelet-Endothelial Cell Adhesion Molecule-1 (PECAM) During Acute Pain in Patients with Sickle Cell Disease.
Causes of Blindness in Adult Patients with Sickle Cell Disease
Changes in Plasma Endothelin-1 Levels and Platelet-Endothelial Cell Adhesion Molecule-1 (PECAM) During Acute Pain in Patients with Sickle Cell Disease.
Peripheral Arterial Tonometry in assessing Endothelial Dysfunction in Pediatric Sickle Cell Disease
The Role of Tonsilloadenoidectomy in the Treatment of Obstructive Sleep Apnea in Children with Sickle Cell Disease
Acute splenic sequestration in a cohort of children derived from the Newborn Screening Program for sickle cell anemia in Minas Gerais, Brazil
Relationship of Hemolysis, Erythropoietin, Other Biologic Mediators and Hydroxyurea Therapy to Tricuspid Regurgitant Jet Velocity in Children and Adolescents with Sickle Cell Disease
Prevalence of Sleep-Related Disorders in Children with Sickle Cell Disease
Opioids Used to Treat Pregnant Women with Sickle Cell Disease May Cause Neonatal Abstinence Syndrome
FULL-DOSE OPIOID FOR THE TREATMENT OF ACUTE PAIN IN SICKLE CELL DISEASE
The right to quality health care - mother and daughter community advocates
The Medical Home as a Tool to Overcome Health Disparities in Sickle Cell Disease
Transition: From Cradle to Commencement
Education through Collaborative Efforts
Building a Network of Care
Increasing the Knowledge of Sickle Cell Disease (SCD) in Public Schools located in Howard County, Maryland
Trait Clinics in Your Neighborhood: A Positive Response
Sickle Cell Walk-A-Thon Supports Adults Living With Sickle Cell Disease
Coordinating Multiple Pediatric Hospital Transitions: The University of Illinois Comprehensive Sickle Cell Center's Transition and Resource Fair
Project Infant: An Integrated Newborn Family Accessibility Network Template
Education in Nutrition for the Sickle Cell Patient Alison R. Maynard-Thompson RN/ Memorial Health care System-SCDH
Steps to Success: Using the Chronic Disease Self-Management Program in Sickle Cell Disease
Education in Nutrition for the Sickle Cell Patient Alison R. Maynard-Thompson RN/ Memorial Health care System-SCDH
Ease On Down the Road Sickle Cell Game
A Novel approach to pain management in the Sickle Cell population
The Efficacy of an Educational Program on the Outcome of Children with Sickle Cell Disease at the Children's Cancer Center of Lebanon.
Barriers encountered in Effective Newborn Screening Trait Follow-up
WESTERN PENNSYLVANIA SICKLE CELL NETWORK: ACCOMPLISHMENTS THROUGH INTEGRATION, EDUCATION, AND PRODUCT DEVELOPMENT
Transition Modules for Adolescents and Young Adults with Sickle Cell Disease
Newborn Screening for Hemoglobinopathies: It's Not Just About Sickle Cell Anemia.
Patient Education and Nurses Education Can Improve Compliance in Sickle Cell Patients Joyce Brownlee NP-C, Clinical Manager, Sickle Cell Day Hospital, Memorial Regional Hospital
Ability of Recent Sickle Cell Pain to Predict Subsequent-Month Pain: the PiSCES Project
Within-Subject Predictive Ability of Measures of Sickle Cell Pain: The PiSCES Project
Using Pregnancy Risk Assessment Monitoring System (PRAMS) for different public health programs - Lessons Learned
The Prevalence and Correlates of Hospital Discharge Against Medical Advice Among Adults with Sickle Cell Disease
Public Health Genomics: From Gene Discovery to Population Health
Health Care Utilization and Expenditures for Privately and Publicly Insured Children with Sickle Cell Disease in the United States
Trends in Pediatric Sickle Cell Disease-Related Mortality in the United States, 1983-2002
Microalbuminuria as a marker of nephropathy in sickle cell disease: correlation with fetal hemoglobin and uric acid.
Predictive Ability of Intermittent Diary Assessment of Long-Term Sickle Cell Pain: the PiSCES Project
Bilateraliy of Pain in Sickle Cell Disease: The PiSCES Project
Mortality rate and causes of death in children from the Newborn Screening Program for Sickle Cell Disease in Minas Gerais, Brazil: a population-based prospective study
SOCIAL SERVICES IN NEWBORN SCREENING
NEWBORN SCREENING FOR SICKLE CELL DISEASE IN THE STATE OF RIO DE JANEIRO
AUTISM SURVEILLANCE AND EPIDEMIOLOGY ACTIVITIES AT THE U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION
Genetic Ancestry of Sickle Cell Anemia Patients
Improving the Care of Adult SCD Patient through a Community Continuum of Care: A Case Study of Four-County Program in North Carolina
Building a Medical Home for those with Sickle Cell Disease: Learning from the ANSCAPE Primary Care Improvement Process Model for Federally Qualified Health Centers
Transition for patients with sickle cell disease: Is it possible to have a successful transition experience in communities without access to adult sickle cell programs?
Chart Card: A Tool for Improving Emergency Room Care in Sickle Cell Disease
Rural and Urban Sickle Cell Patient Access to Transcranial Doppler Screening Impacts The Incidence of Stroke in The Children and Youth Sickle Network (The CYSNSM).
A Model of Coordinated Comprehensive Care for Pediatrics and Adult Patients with Sickle Cell Disease in Brooklyn, New York
External evaluation of Newborn screening for Sickle Cell Disease in Ghana
External evaluation of Newborn screening for Sickle Cell Disease in Ghana
Pain Management and Addiction: Unique problem in Nigerian Patients with SCD
Local and International Partnership to Improve Sickle Cell Disease in Oyo State Nigeria
LIVING WITH SICKLE CELL PAIN AS A NIGERIAN CHILD, BONE MARROW TRANSPLANT, AND OUR RAY OF HOPE.
LIVING WITH SICKLE CELL PAIN AS A NIGERIAN CHILD, BONE MARROW TRANSPLANT, AND OUR RAY OF HOPE.
The Role of Interpersonal Relationships in Health Status Outcomes of SCD
Hospital Self-Discharge Among Adults with Sickle Cell Disease: Associations with Trust and Provider Communication
Education Related to Sickle Cell Disease as a Mechanism to Bridge Research and Clinical Practice
The Impact of Purpose in Life (PIL) on Experiences of Pain in Patients with Sickle Cell Disease
Pregnancy, Sickle Cell Disease, and the Impact on Infant Mortality
Relationships among Spirituality, Self-Efficacy and Quality of Life in Adults with Sickle Cell Disease
Assessment of Neurodevelopment with Brigance Screening in 3-year-old Children with Sickle Cell Disease
Autonomic nervous system reactivity in children with sickle cell disease
An Evaluation of the Impact of Newborn Screening and Genetic Counseling on Families with Trait: A Five Year Prospective Study
Preparing for Transition: An Examination of Health Literacy among Adolescents with Sickle Cell Disease
Alcohol Consumption Among Adults with Sickle Cell Disease
Barriers to Care, Health-Related Quality of Life and Healthcare Satisfaction in Pediatric Sickle Cell Disease
Predictors of Self Efficacy for Coping with Pain in Individuals with Sickle Cell Disease (SCD)
The Effects of Active Coping in Sickle Cell Disease (SCD): A Replication
The Effects on Adoption on Psychological Functioning in Patients with Sickle Cell Disease (SCD)
Social Workers Role in Coordinating Medical, Psychosocial, Educational, and Vocational Transitioning with Teens and Young Adults with Sickle Cell Disease
One-Stop Clinics Improve Follow-up Compliance Loretta Etienne; Memorial Regional Hospital/Sickle Cell Services
The Influence of Caring and Over-Protection during Childhood on Self-Efficacy in Individuals with Sickle Cell Disease
Screening for Sickle Cell Lung Disease in a Pediatric Sickle Cell Clinic
Use of an Internet-Based, Care Coordination Tool In Patient-Centered, Collaborative Care
Joint Commission Sickle Cell Disease Specific Care - Accountability that Works
Sickle Cell Disease Specific Care: Post Hospital Stay Continuity of Care Improves Outcomes
One-Stop Clinics Improve Follow-up Compliance Loretta Etienne, MSW; Memorial Regional Hospital/Sickle Cell Services, Hollywood, FL.
USING BEST PRACTICES IN A SICKLE CELL DISEASE CLINICAL GUIDELINE
Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy (walk-PHaSST): Background, Rationale, Study Design, Current Enrollment and Baseline Data
Fat Emboli Syndrome: A Cause of Sudden Death In A Sickle Cell Patient
Sickle Cell Disease, Hydroxyurea, Mycoplasma and Thromboembolic Disease
Osteonecrosis: Bone Marrow Injection
Clinical Vignette # 310
Case Study Category Pediatric Type: Pain and Inflammation in a patient with sickle cell disease
Case Study Category Pediatric Type: Pulmonary Hypertension in a Patient with Sickle Cell Disease
International Partnership to Improve Sickle Cell Disease in Osun State Nigeria
International Partnership to Improve Sickle Cell Disease in Oyo State Nigeria
International Partnership to Improve Sickle Cell Disease in Oyo State Nigeria
ADVOCACY
Case Study Category Pediatric Type: Massive Iron Overload in a not so frequently transfused aplastic anemia patient with liver transplant
Case Study Category Pediatric Type: Massive Iron Overload in a not so frequently transfused aplastic anemia patient with liver transplant
Transferrin Saturation: A forgotten test for the diagnosis of Iron overload and response to Exjade therapy
Exjade in geriatric patients with sickle cell anemia: A call for caution
Successful management of two episodes of acute chest syndrome without transfusion in a Jehovah's Witness patient with Sickle Cell Disease.
Acute Chest Syndrome in A Jehovah Witness Patient
Automated Red Cell Exchange Transfusion for a Sickle Cell Adult Patient
Case Study Category Pediatric Type: Delayed Hemolytic Transfusion Reaction in a Patient with Sickle Cell Disease
Chief complaint:
Sickle Cell Disease, Asthma and Steroids
Clinical vignette: The Issue of Opioid Dependence in Patients with Sickle Cell Disease
Case Study Category Pediatric Type: Difficult pain management in a Patient with Sickle Cell Disease
Opiate-induced Ileus Masquerades Sickle Cell Abdominal Crisis
Interpretation of Urine Drug Testing in Adult Patients with Sickle Cell Disease on Chronic Opioid Therapy
Case Study Category Pediatric Type: Difficult pain management in a Patient with Sickle Cell Disease
International Partnership to Improve Sickle Cell Disease in Oyo State Nigeria
Sickle Cell Trait With Autoimmune Hemolytic Anemia Diagnosed As Sickle Cell Anemia: Results of Negative Consequences
Case Study Category Pediatric Type: Hematuria in a patient with sickle cell trait
Inhaled Nitric Oxide Use For Acute Chest Syndrome
Global Iron Connections Between Desert Dust, Ocean Biogeochemistry and Climate Tim Jickells, University of East Anglia, Norwich, UK
Iron and Oxygen Sensing Peter Ratcliffe, University of Oxford, UK
Erythropoiesis Olivier Hermine, Institut Pasteur, Paris, France
Ineffective Erythropoiesis in Beta-Thalassemia Stefano Rivella, Cornell University, New York, USA
Iron Overload in Myelodysplastic Syndromes Mario Cazzola, Pavia, Italy
MRI for Cardiac Iron Evaluation John Wood, Los Angeles, USA
State of Art of Iron Chelation Therapy Maria Cappellini, Milan, Italy
Future Therapeutic Approaches to Target Imbalances in Iron Homeostasis Antonello Pietrangelo, Modena, Italy
Iron Metabolism in Yeast Caroline Philpott, University of UTA, USA
Siderophores and the Battle for Iron by Aspergillus Hubertus Haas, Innsbruck Medical University, Austria
The Immune System at the Crossroads of Iron Metabolism Maria de Sousa, ICBAS, University of Porto, Portugal
Iron and Host-Pathogen Interactions Andrew Prentice, London School of Hygiene and Tropical Medicine, UK
Role of Mitochondria in Iron-Sulfur and Iron Metabolism Roland Lill, Philipps Universität Marburg, Marburg, Germany
Hepcidin Regulation and Processing Sophie Vaulont, Université Paris Descartes, CNRS, Paris, France
Iron Metabolism in Plants Mary Lou Guerinot, Dartmouth College, Hanover USA
Iron Metabolism in C. elegans Iqbal Hamza, University of Maryland, USA
Iron Metabolism in Zebrafish Barry Paw, Harvard Medical School, USA
Iron Metabolism in Mammals Marie-Paule Roth, Toulouse University, France
Imaging the Distribution of Iron-Ferritin-Hemosiderin at the Subcellular Level Carmen Quintana, Instituto Microelectronica de Madrid, Spain
Spacial Coordination of Cell-Adhesion Molecules and Redox Cycling of Iron in Pulmonary Blast Injury Nikolai Gorbunov, Silver Spring, Maryland, USA
Shuttling Iron Between Cellular Organelles Ioav Cabantchik, Hebrew University of Jerusalem, Israel
Drug Targeting to the Brain Using the Transferrin Receptor Ruben Boado, UCLA, USA
Iron and the Brain Torben Moos, Aalborg University, Denmark
Iron-Sulfur Cluster Biogenesis and Human Disease Tracey Rouault, National Institute of Neurological Disorders and Stroke, Bethesda, USA
Hemochromatosis - Screening and Penetrance Katie Allen, University of Melbourne, Australia
Hereditary Hemochromatosis as a Conformational Disorder Matthew W. Lawless, Trinity College Dublin, Ireland
Iron as Engine of Basic Biological Processes and Disease: The Future of BioIron Nancy Andrews, Duke University, USA
IDENTIFYING GENES ESSENTIAL FOR HEME BIOSYNTHESIS THROUGH LARGE-SCALE GENE EXPRESSION SCREENING
FPN1B, A NOVEL FERROPORTIN TRANSCRIPT LACKING AN IRON-RESPONSIVE ELEMENT, ENABLES DUODENAL AND ERYTHROID PRECURSOR CELLS TO EVADE TRANSLATIONAL REPRESSION
LYSOSOMAL PROTEOLYSIS IS THE PRIMARY DEGRADATION PATHWAY FOR CYTOSOLIC FERRITIN AND IS NECESSARY FOR IRON EXIT FROM FERRITIN
LIVE IMAGING OF METAL-ION TRANSPORT IN OOCYTES EXPRESSING HUMAN DIVALENT METAL-ION TRANSPORTER-1 (DMT1): SUBSTRATE PROFILE AND SELECTIVITY
IMAGING OF IRON ENTRY AND IRON-MEDIATED TOXICITY IN PRIMARY NEURONS AND ASTROCYTES
CHARACTERIZATION OF HOLO-TF-REGULATED TFR2 TRAFFICKING
ABCB10 INTERACTS WITH MITOFERRIN-1 (SLC25A37) TO ENHANCE ITS PROTEIN STABILITY AND FUNCTION TO IMPORT MITOCHONDRIAL IRON IN ERYTHROBLASTS
EXPRESSION OF MITOCHONDRIAL FERRITIN AFFECTS JAK2/STAT5 PATHWAY IN K562 CELLS
STRESS ERYTHROPOIESIS AND IRON MOBILIZATION IN A MOUSE MODEL MIMICKING ANEMIA OF CHRONIC DISEASE; RESPONSE TO ERYTHROPOIETIN INJECTIONS
DIFFERENTIAL EXPRESSION OF IRON METABOLISM GENES AND IRON HANDLING IN DISTINCT POPULATIONS OF HUMAN INFLAMMATORY MACROPHAGES
THE ACTIVATION OF IRON REGULATORY PROTEIN 1 DOMINATES IRON HOMEOSTASIS IN INFLAMED INTESTINAL EPITHELIUM
ROLE OF TOLL-LIKE RECEPTOR / ADAPTOR PROTEIN MYD88 SIGNALING IN HYPOFERREMIA ASSOCIATED WITH INFLAMMATION
ENDOTOXIN-MEDIATED INDUCTION OF HEPCIDIN EXPRESSION IS ATTENUATED IN TFR2 MUTANT MICE DESPITE NORMAL ACTIVATION OF STAT3
FUNCTION OF THE IRE/IRP REGULATORY NETWORK IN MACROPHAGES
FUNCTION OF THE IRE/IRP REGULATORY NETWORK IN SYSTEMIC IRON METABOLISM AND CENTRAL ORGANS FOR IRON HOMEOSTASIS
A NOVEL IRP2-/- MOUSE MODEL DISPLAYS LOCOMOTOR DYSFUNCTION AND NEURONAL IRON ACCUMULATION
GENOME-WIDE MRNA IDENTIFICATION AND PROTEOMIC ANALYSIS OF THE IRE/IRP REGULATORY NETWORK
DEGENERATION OF MOTOR NEURONS IN THE SPINAL CORD OF IRP NULL MICE
FERROCHELATASE DEFICIENCY IN ERYTHROPOIETIC TISSUES OF MICE LACKING IRON REGULATORY PROTEIN 2
IRON-INDEPENDENT PHOSPHORYLATION OF IRP2 REGULATES G2/M TRANSITION DURING CELL CYCLE PROGRESSION
HIF-2 ALPHA BUT NOT HIF-1 ALPHA IS A KEY REGULATOR OF IRON ABSORPTION
BMP-SMAD SIGNALING IS IMPAIRED IN AN HFE KO MOUSE MODEL
PHOSPHORYLATION OF RECEPTOR-ACTIVATED SMAD1/5/8 IS NOT ENHANCED IN HFE-DEFICIENT MICE DESPITE INCREASED BMP6 EXPRESSION
INTERACTION OF THE HEREDITARY HEMOCHROMATOSIS PROTEIN, HFE, WITH TRANSFERRIN RECEPTOR 2 IS REQUIRED FOR TRANSFERRIN-INDUCED HEPCIDIN EXPRESSION
REGULATION OF HEPCIDIN BY DIETARY IRON IN MICE WITH FUNCTIONAL LOSS OF HFE AND TRANSFERRIN RECEPTOR 2
INVESTIGATION OF HFE-DEPENDENT REGULATION OF HEPCIDIN EXPRESSION
IRON DEPENDENT REGULATION OF MDM2 INFLUENCES P53 ACTIVITY AND HEPATIC CARCINOGENESIS
IRON CHELATORS FOR THE TREATMENT OF PANCREATIC CANCER: MECHANISM OF ACTION INVOLVING THE IRON-REGULATED GROWTH AND METASTASIS SUPPRESSOR, NDRG-1
FERRITIN H INDUCTION BY HISTONE DEACETYLASE INHIBITORS
IRON TRANSPORT PROTEINS ARE INFLUENCED BY WNT SIGNALLING
DEFERASIROX IS THE ONLY IRON CHELATOR INDUCING NF-KB INHIBITION IN MDS PATIENTS AND IN LEUKEMIC CELL LINES AND ACTS INDEPENDENTLY FROM REACTIVE OXYGEN SPECIES REDUCTION
CHARACTERIZATION OF THE PROMOTER REGION OF THE HAMP GENE IN THE BLACK SOUTH AFRICAN POPULATION AND ITS POSSIBLE ASSOCIATION WITH OESOPHAGEAL CANCER
IRON UPTAKE IN GRAM-NEGATIVE BACTERIA: THE ROLE OF PERIPLASMIC PROTEINS IN SIDEROPHORE AND HEME TRANSPORT
THE ADAPTATION TO DIFFERENT DEGREES OF IRON DEFICIENCY IN SACCHAROMYCES CEREVISIAE DEPENDS ON THE AUTO- AND CROSSREGULATION OF THE MRNA-DESTABILIZING PROTEINS CTH1 AND CTH2
HEPCIDIN: A CLUE FOR THE ROLE OF LYMPHOCYTES IN IRON HOMEOSTASIS
INCREASED PHOSPHORYLATION OF SMAD1/5/8 AND HEPCIDIN EXPRESSION IN RESPONSE TO LPS IN BMP6-DEFICIENT MICE
CELLULAR TRAFFICKING OF IRON AND IRON SULFUR CLUSTERS: THE ROLE OF MITONEET, A NOVEL OUTER MITOCHONDRIAL MEMBRANE PROTEIN WITH A LABILE IRON SULFUR CLUSTER
HUMAN TRANSFERRIN RECEPTOR-1 IS AN ENDOCYTOSING RECEPTOR FOR H-FERRITIN
PRODUCTION OF CORRECTLY-FOLDED, BIOLOGICALLY-ACTIVE HEPCIDIN ENABLED REVISION OF THE PUBLISHED HEPCIDIN STRUCTURE AND GENERATION OF NEUTRALIZING ANTIBODIES
HEPCIDIN INDUCED INTERNALIZATION OF FERROPORTIN REQUIRES BINDING AND COOPERATIVE INTERACTION WITH JAK2
MECHANISMS OF HEPCIDIN INHIBITION BY NOVEL TMPRSS6 (MATRIPTASE-2) MUTATIONS ASSOCIATED WITH IRIDA
HEMOJUVELIN/NEOGENIN INTERACTION IS REQUIRED FOR BMP4-INDUCED HEPCIDIN EXPRESSION
RESULTS OF THE FIRST INTERNATIONAL ROUND ROBIN FOR THE QUANTIFICATION OF URINARY AND PLASMA HEPCIDIN ASSAYS: NEED FOR STANDARDISATION
ANTI-HEPCIDIN THERAPY IS AN EFFECTIVE TREATMENT FOR THE ANEMIA OF INFLAMMATION IN MICE
CHARACTERIZATION AND EXPRESSION ANALYSIS OF IMMUNE-RELATED IRON GENES DURING EXPERIMENTAL IRON OVERLOAD AND INFECTION IN FISH
THE HEMOCHROMATOSIS-ASSOCIATED HFE MUTATION PROTECTS MICE FROM SALMONELLA TYPHIMURIUM INFECTION VIA INDUCTION OF LIPOCALIN 2
MYCOBACTERIA-INDUCED ANAEMIA REVISITED: A MOLECULAR APPROACH REVEALS THE INVOLVEMENT OF NRAMP-1 AND LIPOCALIN- 2, BUT NOT OF HEPCIDIN
HEME SENSITIZATION TO TNF-MEDIATED PROGRAMMED CELL DEATH DICTATES THE OUTCOME OF PLASMODIUM INFECTION IN MICE
THE AVIAN LIPOCALIN EX-FABP IS A SIDEROPHORE BINDING ANTIBACTERIAL PROTEIN
HEPCIDIN INDUCTION BY PATHOGEN-ASSOCIATED STIMULI
LIVER-SPECIFIC DELETION OF FRATAXIN IN THE MOUSE AS A NEW MODEL TO UNDERSTAND IRON DYSREGULATION IN FRIEDREICH ATAXIA
IRON STORES AND IRON ABSORPTION IN HEREDITARY HEMOCHROMATOSIS
HYPERGLYCEMIA AND IMPAIRED BETA-CELL FUNCTION CAUSED BY IRON REGULATORY PROTEIN 2 DEFICIENCY
ALTERATIONS OF SYSTEMIC AND MUSCLE IRON METABOLISM IN HUMAN SUBJECTS TREATED WITH LOW DOSE RECOMBINANT ERYTHROPOIETIN
ANALYSIS OF CONDITIONAL FERRITIN H DELETION IN MOUSE ADULT HEART
EFFICACY AND SAFETY OF DEFERASIROX (EXJADE®) IN REDUCING AND PREVENTING MYOCARDIAL SIDEROSIS IN PATIENTS WITH BETATHALASSEMIA
NRAMP1 PROMOTES EFFICIENT IRON RECYCLING FOLLOWING ERYTHROPHAGOCYTOSIS IN VIVO
INCREASED HEPCIDIN EXPRESSION IN MICE AFFECTED BY BETA-THALASSEMIA REDUCES IRON OVERLOAD WITH NO EFFECT ON ANEMIA
THE ROLES OF HEPCIDIN AND INFLAMMATION IN ANEMIA OF CANCER
MUTATIONS IN A NOVEL MITOCHONDRIAL TRANSPORTER GENE CAUSE AUTOSOMAL RECESSIVE CONGENITAL SIDEROBLASTIC ANEMIA
ALLELIC HETEROGENEITY OF TMPRSS6 MUTATIONS IN IRIDA
THE ROLE OF ERYTHROPOIETIN IN FAMILIAL AMYLOIDOSIS TTR V30M
LIPID RAFTS BREAKDOWN DECREASES THE ACTION OF HEPCIDIN ON MACROPHAGE FERROPORTIN
HEPCIDIN, THE HORMONE OF IRON METABOLISM, IS BOUND SPECIFICALLY TO Alpha2-MACROGLOBULIN IN BLOOD
IRON-DEPENDENT REGULATION OF FERRITIN BY HIF-1 IN C. ELEGANS
CHARACTERISATION OF THE INTERACTION BETWEEN CERULOPLASMIN AND LACTOFERRIN
MAGNETIC DYNAMIC SUSCEPTIBILITY MEASUREMENTS AS A PRE-SCREENING TOOL TO INVESTIGATE THE PRESENCE OF FERRITIN IN DIFFERENT ORGANISMS
RELEVANCE OF COMMON POST-TRANSLATION MODIFICATIONS OF HUMAN SERUM ALBUMIN FOR NON-TRANSFERRIN-BOUND IRON SPECIATION
RETINAL DEGENERATION IN CP, HEPH, FPN AND HEPC MUTANT MOUSE MODELS AMELIORATED BY IRON CHELATION
THE LIVER-SPECIFIC MICRORNA 122A REGULATES THE EXPRESSION OF HFE, HFE2 AND HEPCIDIN AND CONTROLS SYSTEMIC IRON HOMEOSTASIS
-153 C/T MUTATION IN HEPCIDIN PROMOTER MAY IMPACT PRESENTATION OF HFE RELATED GENETIC IRON OVERLOAD
THE PATHOGENESIS OF HEREDITARY HEMOCHROMATOSIS
A NOVEL TRANSFERRIN/TFR2-MEDIATED MITOCHONDRIAL IRON TRANSPORT SYSTEM IS DISRUPTED IN PARKINSON'S DISEASE
DOMINANT MUTANTS OF CERULOPLASMIN INDUCE GOLGI FRAGMENTATION AND IMPAIRMENT OF THE COPPER LOADING MACHINERY IN ACERULOPLASMINEMIA
HUMAN AMYLOID-B BINDS HEME TIGHTLY: WHY HUMANS BUT NOT RODENTS DEVELOP ALZHEIMER'S DISEASE
REGULATION OF IRON TRANSPORT ACROSS THE BLOOD BRAIN BARRIER
THE CHOROID PLEXUS IS A SITE FOR REGULATING BRAIN IRON HOMEOSTASIS
DESFERRIOXAMINE AND DEFERIRSIROX TRAVERSE THE BLOOD BRAIN BARRIER AND PREVENT DEGENERATION OF DOPAMINE NEURONS IN THE 6-HYDROXY DOPAMINE MODEL OF PARKINSON'S DISEASE
USE OF JAK2 INHIBITORS TO LIMIT INEFFECTIVE ERYTHROPOIESIS AND IRON ABSORPTION IN MICE AFFECTED BY BETA-THALASSEMIA MAJOR, N° 79
EXOGENOUS TRANSFERRIN AMELIORATES DISEASE IN BETA-THALASSEMIC MICE
DEVELOPMENT OF BMP ANTAGONISTS FOR EXPERIMENTAL AND THERAPEUTIC CONTROL OF HEPCIDIN EXPRESSION
NATURAL AND SYNTHETIC STAT3 INHIBITORS REDUCE SIGNIFICANTLY HEPCIDIN EXPRESSION IN DIFFERENTIATED MOUSE HEPATOCYTES EXPRESSING THE ACTIVE PHOSPHORYLATED FORM OF STAT3
GENE REGULATION THERAPY UTILIZING FERRITIN HEAVY CHAIN
MINIHEPCIDINS: SMALL PEPTIDES INVOLVED IN DISULFIDE EXCHANGE WITH FERROPORTIN ACT AS AGONISTS
HFE MUTATIONAL ANALYSIS HAS REDUCED THE NEED FOR LIVER BIOPSY AT DIAGNOSIS BUT NOT IMPACTED ON INITIAL DISEASE BURDEN IN HEREDITARY HAEMOCHROMATOSIS PROBANDS
HERITABILITY OF SERUM IRON MEASURES IN THE HEMOCHROMATOSIS AND IRON OVERLOAD SCREENING (HEIRS) FAMILY STUDY
TFR2-RELATED HEREDITARY HEMOCHROMATOSIS IN JAPAN
IRON OVERLOAD IN THE ASIAN COMMUNITY
DELETION OF THE HFE GENE IS PRESENT AT THE POPULATION LEVEL IN SARDINIA
DO ALL HEMOCHROMATOSIS PATIENTS ORIGINATE FROM THE SAME ANCESTRAL ORIGIN BY MITOCHONDRIAL DNA ANALYSIS?
A NEW FLVCR ISOFORM ABLE TO SUPPORT ERYTHROPOIESIS
ABSENCE OF THE HEMOCHROMATOSIS GENE HFE CONFERS PROTECTION UNDER CONDITIONS OF STRESS ERYTHROPOIESIS
A CLOSER LOOK AT CELLULAR IRON METABOLISM IN IRP2 DEFICIENT ERYTHROBLASTS
DOES HEME OXYGENASE 1 PLAY A ROLE IN ERYTHROID DIFFERENTIATION?
LOW HEPCIDIN AND ELEVATED GDF15 LEVELS IN PATIENTS WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
TRANSFERRIN RECEPTOR ACTIVATION BY POLYMERIC IGA1 MODULATES CYTOKINE THRESHOLD OF EARLY ERYTHROBLASTS
STUDYING IRON METABOLISM IN ERYTHROID CELLS UNDER DIFFERENT OXYGEN CONDITONS
FRATAXIN EXPRESSION LEVELS DURING INCREASED HEME SYNTHESIS IN K562 CELLS
CHARACTERIZATION OF IRON METABOLISM AND ANEMIA IN A MOUSE MODEL OF CONGENITAL ERYTHROPOIETIC PORPHYRIA
REGULATION OF IRON HOMEOSTASIS IN ANEMIA OF CHRONIC DISEASES AND IRON DEFICIEANCY ANEMIA: DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS
COPPER-DEFICIENT ANEMIC RATS, BUT NOT MICE, UP-REGULATE FERROPORTIN EXPRESSION AND DOWN-REGULATE HEPCIDIN
HIGH PHOSPHATE CONCENTRATIONS DISRUPT IRON LOADING INTO FERRITIN FORMING IRON (III)-PHOSPHATE COLLOID PARTICLES: CORRELATIONS TO NON-TRANSFERRIIN BOUND IRON IN CHRONIC KIDNEY DISEASE
FERRIC PYROPHOSPHATE: BIOCHEMICAL CHARACTERISATION AND METABOLIC FATE IN HEPG2 CELLS
ERYTHROPOIETIC AND IRON FEATURES IN THE DIFFERENT CLINICAL FORMS OF HEREDITARY SPHEROCYTOSIS - A PRELIMINARY STUDY
PATHOGENESIS OF ANEMIA IN PREGNANCY AND ANEMIA OF INFLAMMATION ARE SIMILAR
EFFECTS OF RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY ON MODERATE STAGES OF CARDIO-RENAL ANAEMIA SYNDROME - AN EXPERIMENTAL MODEL
ATYPICAL IRON DEFICIENCY ANAEMIA - ASSOCIATION OF TWO NEW MUTATIONS IN FERROPORTIN AND TMPRSS6 GENES
BIOMINERALIZATION IN MAGNETOTACTIC BACTERIA PROCEEDS WITHOUT MINERAL PRECURSOR AND MAGNETOSOMES MOVE DURING CHAIN ASSEMBLY
IRON-SULFUR PROTEINS AND THE NITRIC OXIDE CYTOTOXICITY IN BACTERIA
SERCA PUMP EXPRESSION AND IRON UPTAKE IN A DROSOPHILA CELL LINE
THE IMPACT OF DIETARY COPPER AND ZINC ON DROSOPHILA FERRITIN DISTRIBUTION AND IRON METABOLISM
OVEREXPRESSION OF THE YEAST FRATAXIN HOMOLOG (YFH1): CONTRASTING EFFECTS ON IRON-SULFUR CLUSTER ASSEMBLY, HEM SYNTHESIS AND RESISTANCE TO OXIDATIVE STRESS
KLAFT, THE KLUYVEROMYCES LACTIS ORTHOLOG OF AFT1 AND AFT2, MEDIATES IRON-RESPONSIVE GENE EXPRESSION THROUGH AN AFT-TYPE ELEMENT
HAPTOGLOBIN AND HAPTOGLOBIN-RELATED PROTEIN ARE HEMOGLOBIN-BINDING PROTEINS WITH DIVERSE FUNCTIONS
IRON AND VIRUSES - INTERACTIONS OF HIV-1 WITH CELLULAR IRON METABOLISM
MILD INCREASES IN SERUM HEPCIDIN AND INTERLEUKIN-6 CONCENTRATIONS IMPAIR IRON INCORPORATION IN HEMOGLOBIN DURING EXPERIMENTAL HUMAN MALARIA INFECTION
INTRACELLULAR PARASITE LEISHMANIA DONOVANI MANIPULATES IRON HOMEOSTASIS OF HOST MACROPHAGE BY DEPLETING INTRACELLULAR LABILE IRON POOL
IDENTIFICATION OF A NEW HEXADENTATE IRON CHELATOR CAPABLE OF RESTRICTING THE INTRAMACROPHAGIC GROWTH OF MYCOBACTERIUM AVIUM
ZIP TRANSPORTERS IN LEISHMANIA INFANTUM
EVALUATION OF IRON STATUS IN PATIENTS WITH GASTRITIS AND HELICOBACTER PYLORI INFECTION
IRON-HEME METABOLISM IN LEISHMANIA INFANTUM INTRACELLULAR STAGE
SYNTHESIS AND CHARACTERIZATION OF A NOVEL TRIPODAL CATECHOLATE HEXADENTATE CHELATOR
DIAGNOSTIC ACCURACY OF SERUM HEPCIDIN FOR IRON DEFICIENCY IN CRITICALLY ILL PATIENTS WITH ANEMIA
MHC CLASS I ANTIGEN PRESENTATION: EFFECT OF HFE, A PROTEIN INVOLVED IN IRON METABOLISM
HEPATIC MCP-1 GENE EXPRESSION IS SUPPRESSED IN IRON-LOADED MALE C282Y HOMOZYGOTES AND CORRELATES WITH HEPCIDIN EXPRESSION
INFLAMMATION-INDUCED HEPCIDIN IS ASSOCIATED WITH THE DEVELOPMENT OF ANEMIA IN SEPTIC PATIENTS
INFLAMMATION UPREGULATES NON-TRANSFERRIN BOUND IRON UPTAKE BY HEPATOCYTES
HIGH NUMBERS OF THE MOST MATURE CD8+ EFFECTOR MEMORY T CELLS ARE ASSOCIATED WITH THE NEW GGG HAPLOTYPE, A MARKER OF LESS SEVERE EXPRESSION OF HEREDITARY HEMOCHROMATOSIS
INCREASED FREQUENCY OF CD4+CD28+ T-LYMPHOCYTES IN MICE WITH HFE-DEFICIENCY
ELEVATED ICAM-1 AND SUPPRESSION OF VCAM-1 SERUM PROTEIN IN HEREDITARY HEMOCHROMATOSIS PATIENTS
THE MULTICOPPER OXIDASE CERULOPLASMIN AND THE IRON EXPORTER FERROPORTIN ARE BOTH PRESENT AT THE CELL SURFACE OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES
LEUKOCYTE APOPTOSIS AND INFLAMMATION IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE OR BETA-THALASSEMIA: A MECHANISM FOR INCREASED STROKE AND DISEASE SEVERITY IN SICKLE CELL DISEASE
SYMPOSIUM, WEDNESDAY, JUNE 10, 17:20 VASCULAR INFLAMMATORY RESPONSE AND SPATIAL ARRANGEMENT OF CELL ADHESION MOLECULES ASSOCIATED WITH REDOX CYCLING OF IRON IN PULMONARY BLAST INJURY
ENDOSOMAL TRANSPORT OF TRANSFERRIN TO MITOCHONDRIA IS ESSENTIAL FOR EFFICIENT UTILIZATION OF IRON FOR HEME SYNTHESIS
POTENTIAL INVOLVEMENT OF DMT1 AND ZIP8 IN IRON RELEASE FROM LYSOSOMES
EVIDENCE FOR AN ENDOPLASMIC RETICULUM IRON TRANSPORT SYSTEM
DELIVERY OF IRON FROM TRANSFERRIN TO MITOCHONDRIA VIA PATHWAYS INVOLVING LABILE AND NON-CHELATABLE FORMS OF IRON
HEME AND IRON TRANSPORT SYSTEMS IN NON-POLARIZED AND POLARIZED CELLS
IRON SUPPLY DETERMINES APICAL/BASOLATERAL MEMBRANE DISTRIBUTION OF INTESTINAL IRON TRANSPORTERS DMT1 AND FERROPORTIN 1
SUBCELLULAR DISTRIBUTIONS OF ZIP14 AND DMT1 IN HEPG2 CELLS: IMPLICATIONS FOR CELLULAR IRON IMPORT AND ENDOSOMAL IRON TRANSPORT
FERRITIN DOES NOT DONATE ITS IRON FOR HEME SYNTHESIS IN CULTIVATED MACROPHAGES
SYMPOSIUM, WEDNESDAY, JUNE 10, 17:40 PROBING THE INTERRELATIONSHIPS OF THE CELLULAR LABILE IRON POOLS (LIP) IN NORMAL AND PATHOLOGICAL CONDITIONS: AN OVERVIEW
CHARACTERIZATION OF A POTENTIAL IRON SHUTTLE WITHIN THE CYTOPLASM OF MAMMALIAN CELLS
DIFFERENTIAL PROTEOMIC APPROACH TO INVESTIGATE IRON RESPONSE IN MURINE MACROPHAGES
MITOFERRIN 1 AND 2 ACT AS MITOCHONDRIAL IRON IMPORTERS IN HELA CELLS
THE ASSEMBLY OF RESPIRATORY COMPLEX I REQUIRES THE IRON-SULFUR CLUTER PROTEIN HUIND1
DOWN-REGULATION OF COMPONENTS OF THE IRON-SULFUR CLUSTER ASSEMBLY MACHINERIES IN INFLAMMATORY MACROPHAGES
MITOCHONDRIAL FERRITIN ATTENUATES DOXORUBICIN EFFECTS ON IRON HOMEOSTASIS
A HIGH-THROUGHPUT SIRNA SCREEN FOR HEPCIDIN REGULATORS REVEALS SMAD7 AS A NOVEL NEGATIVE REGULATOR OF HEPCIDIN EXPRESSION
BONE MORPHOGENETIC PROTEIN (BMP)-RESPONSIVE ELEMENTS LOCATED IN THE PROXIMAL AND DISTAL HEPCIDIN PROMOTER ARE CRITICAL FOR ITS RESPONSE TO HJV/BMP/SMAD
RENAL HANDLING OF HEPCIDIN
FURIN AND MAPK (ERK1/2) PARTICIPATE IN THE REGULATION OF HEPCIDIN EXPRESSION IN HEPG2 CELLS
PHYSIOLOGIC AND PATHOPHYSIOLOGIC REGULATION OF HEPCIDIN EXPRESSION
SERUM HEPCIDIN LEVELS IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE: A CONFOUNDING RELATIONSHIP WITH TRANSFUSION CYCLE
HAEM METABOLISM INHIBITORS AFFECT HEPCIDIN EXPRESSION IN MICE
CHARACTERISATION OF THE DIVALENT METAL ION BINDING PROPERTIES OF HEPCIDIN BY FTICR MASS SPECTROMETRY
PREPARATION AND INVESTIGATION OF FLUORESCENT HEPCIDIN IN MDCK CELLS AND MACROPHAGES
HEPCIDIN DEFICIENCY IN PATIENTS WITH CHRONIC HEPATITIS C
EFFECTS OF RECOMBINANT HEPCIDIN, PROHEPCIDIN AND THEIR FLUORESCENT DERIVATIVES ON FERROPORTIN DEGRADATION
HIERARCHY BETWEEN ERYTHROPOIESIS AND IRON AS HEPCIDIN REGULATORS
HEPCIDIN EFFECT ON TRACE ELEMENTS IN SERUM OF WT AND HEPCIDIN1 KNOCKOUT MICE
METABOLIC STEATOSIS AND ALCOHOL-LOADING REGULATE THE EXPRESSION OF TRANSFERRIN RECEPTOR 1 AND HEPCIDIN IN MICE LIVER
HEPCIDIN MEASUREMENT BY QUANTITATIVE SELDI-TOF-MS IN HEMODIALYSIS PATIENTS: EVALUATION OF IRON STATUS DURING ERYTHROPOIESIS-STIMULATING AGENTS THERAPY
RADIOIMMUNOASSAY FOR HUMAN SERUM HEPCIDIN
QUANTITATION OF HEPCIDIN
CONTRIBUTION OF STAT3 AND SMAD4 PATHWAYS TO THE REGULATION OF HEPCIDIN BY OPPOSING STIMULI
REGULATION OF HEPCIDIN EXPRESSION DURING PHENYLHYDRAZINE-INDUCED HAEMOLYTIC ANAEMIA IN MICE
HFE MUTATIONS MODULATE THE EFFECT OF IRON STORES AND INFLAMMATION ON SERUM HEPCIDIN-25 IN CHRONIC HEMODIALYSIS PATIENTS
HEPCIDIN RESPONSE TO ACUTE ORAL IRON AND CHRONIC IRON OVERLOAD IN DYSMETABOLIC HEPATIC IRON OVERLOAD SYNDROME
THE IRON-REGULATING HORMONE HEPCIDIN IS EXPRESSED IN BLADDER CANCER TISSUE AND CORRELATES TO POOR PATIENT SURVIVAL
FIRST DUTCH PATIENT WITH MAPTRIPTASE-2 MUTATION LEADING TO IRON-REFRACTORY IRON DEFICIENT ANEMIA
COMBINED DELETION OF HFE AND TRANSFERRIN RECEPTOR 2 IN MICE LEADS TO MARKED DYSREGULATION OF HEPCIDIN AND IRON OVERLOAD
DISRUPTION OF BOTH HFE AND TFR2 CAUSES MORE SEVERE HEPATIC IRON OVERLOAD IN HEREDITARY HAEMOCHROMATOSIS
EXTRA-HEPATIC HFE FUNCTIONS MAY BE RESPONSIBLE FOR IRON OVERLOAD IN THE HEART AND ALTERATION WITHIN THE ERYTHRON
HFE POLYMORPHISMS AFFECT CHOLESTEROL METABOLISM: INSIGHTS INTO NEURODEGENERATIVE DISEASES
HFE POLYMORPHISMS AND DRUG RESISTANCE IN CANCER
DIFFERENT EFFECTS ON IRON CONTENT IN THE LIVER AND SPLEEN OF HFE-KO MICE AFTER HEPATIC INJECTION OF A LENTIVIRAL VECTOR BEARING THE HFE GENE
HFE IS ESSENTIAL TO INDUCE HEPCIDIN AND TO DEVELOP HYPOFERREMIA IN RESPONSE TO LOW DOSES OF LPS
REDUCED SERUM TRANSFERRIN LEVELS CHARACTERISE IRON-LOADED C282Y HAEMOCHROMATOSIS DESPITE UPREGULATED HEPATIC TRANSFERRIN TRANSCRIPTION
HEMOJUVELIN IN MOUSE TISSUES
HOMOZYGOUS DELETION OF HFE AS A CAUSE OF HEMOCHROMATOSIS IN SARDINIA
HFE PROTEIN PRODUCED IN EUKARYOTIC CELLS BINDS THE CATION INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR IN VITRO
E277K AND V295A HFE MUTATIONS - A MATTER OF α3-DOMAIN LOCATION?
DIFFERENTIAL EXPRESSION OF HFE SPLICE VARIANTS
TFR2 BETA ISOFORMS ARE DIFFERENTIALLY LOCALIZED IN CELLS AND RESPOND DIFFERENTLY TO IRON TREATMENT
CHARACTERIZATION OF MOUSE SERUM FERRITIN
POSTNATAL INCREASES IN HEPCIDIN EXPRESSION AT BIRTH AND AT WEANING ARE DEPENDENT ON TRANSFERRIN RECEPTOR 2
THE ROLE OF DCYTB IN INTESTINAL IRON ABSORPTION
ERYTHROPOIETIN INCREASES IRON ABSORPTION BY HUMAN INTESTINAL EPITHELIAL CELLS
ALTERNATIVE FERRITIN MRNA TRANSLATION UNDER STRESS CONDITIONS VIA INTERNAL INITIATION
IN-CELL-WESTERN ANALYSIS OF ENDOGENOUS FERROPORTIN REGULATION IN PRIMARY MACROPHAGES
ROLE OF MUCIN 13 IN IRON METABOLISM
A NOVEL MUTATION IN INTESTINAL ISOFORM OF DIVALENT METAL TRANSPORTER 1 (DMT 1A)
UPSTREAM STIMULATORY FACTORS (USF-1/USF-2) REGULATE HUMAN HEMOJUVELIN GENE EXPRESSION
REDOX CONTROL OF IRON REGULATORY PROTEIN 2 STABILITY
STRUCTURAL STUDIES OF THE SOUL/HBP FAMILY OF HEME BINDING PROTEINS
STRUCTURAL ANALYSIS OF HEMIN DEMETALLATION BY L-CHAIN APOFERRITINS
DEFINITION OF THE RESIDUES REQUIRED FOR THE INTERACTION BETWEEN GLYCINE-EXTENDED GASTRIN AND TRANSFERRIN IN VITRO
DMT1 EXPRESSION CAN LEAD TO ACCUMULATION OF METALS IN CELLS
AGGREGATION AND DISSOCIATION OF PEA SEED FERRITIN REGULATED BY PH AND FERRIC ION
THE EFFECT OF COPPER LOADING AND DEPLETION ON IRON TRANSPORTER EXPRESSION IN CACO-2 CELLS
ACTIVATION OF AN UNFOLDED PROTEIN RESPONSE MODULATES THE EXPRESSION OF IRON-RELATED GENES
BMP6 IS A KEY ENDOGENOUS REGULATOR OF HEPCIDIN EXPRESSION AND IRON METABOLISM
FUNCTION OF THE IRP/IRE REGULATORY NETWORK IN HEPATOCYTES
FUNCTINAL RNAI SCREEN IDENTIFIES CCL2 (MCP-1) AS A NOVEL REGULATOR OF TRANSFERRIN UPTAKE
HEPCIDIN TRIGGERS REDUCTION IN DMT1 PROTEIN IN INTESTINAL CELLS
INTESTINAL IRON ABSORPTION IN NEONATAL RATS DOES NOT CORRELATE WITH CHANGES IN THE EXPRESSION OF THE IRON REGULATORY HORMONE HEPCIDIN
PHLEBOTOMY-INDUCED IRON MOBILISATION FROM TISSUES OF HJV-/-MICE
THE ROLES OF IRON AND FERRITIN IN ISCHEMIC PRECONDITIONING OF THE NON-DIABETIC AND DIABETIC HEART
IMMUNOASSAY FOR HUMAN HEPCIDIN IN BLOOD AND DEVELOPMENT OF A PROTOTYPE ELISA KIT
ALTERATIONS IN IRON STATUS ARE ASSOCIATED WITH CHANGES IN THE CHOLESTEROL BIOSYNTHESIS PATHWAY
DIFFERENCES IN GENE EXPRESSION OF DUODENAL IRON TRANSPORTERS IN HEMOCHROMATOSIS SUBJECTS WITH AND WITHOUT IRON OVERLOAD
IDENTIFICATION OF AN IRON-REGULATED E3 UBIQUITIN LIGASE AND ITS ROLE IN IRON REGULATORY PROTEIN 2 STABILITY
59FE-DISTRIBUTION IN CONDITIONAL FERRITIN H KNOCKOUT MICE
GENOME-WIDE SIRNA SCREEN TO IDENTIFY REGULATORS OF THE HEPCIDIN/FERROPORTIN REGULATORY SYSTEM
DAILY REGULATION OF SERUM AND URINARY HEPCIDIN IS NOT INFLUENCED BY SUBMAXIMAL CYCLING-BASED EXERCISE IN HUMANS WITH NORMAL IRON METABOLISM
ARABIDOPSIS NRAMP1 IS REQUIRED FOR HIGH-AFFINITY MANGANESE UPTAKE BY THE ROOT
THE STRUCTURE OF THE HEPCIDIN-FERROPORTIN BINDING INTERFACE
TWO TFR2 MICE MODELS REPRODUCE HEMOCHORMATOSIS TYPE 3 AND CAN GIVE INSIGHT INTO MOLECULAR MECHANISMS OF TFR2 PROTEIN
DEGRADATION PATHWAYS OF HUMAN IRON REGULATORY PROTEIN 2
METABOLIC REGULATION OF IRON HOMEOSTASIS IN HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA
HEPATIC COPPER CONTENT IS REDUCED IN WILSON DISEASE KNOCKOUT MICE FED AN IRON-ENRICHED DIET
FPN1 INTERACTS WITH HEPHAESTIN AND HEME OXYGENASE 1 BUT NOT ABCG2 IN INTESTINAL IRON ABSORPTION
HEREDITARY HAEMOCHROMATOSIS PROTEIN (HFE)-DEPENDENT REGULATION OF IRON TRANSFER ACROSS PLACENTA
GENERATION OF A MOUSE STRAIN WITH INDUCIBLE IRP1 OVEREXPRESSION: A NEW MODEL FOR UNDERSTANDING IRON METABOLISM DISORDERS
EXPRESSION OF GENES INVOLVED IN IRON IMPORT/EXPORT IN HUMAN INTESTINAL AND LIVER CELLS: EFFECT OF IRON AVAILABILITY AND MODULATION BY ETHANOL
INTERRELATIONS BETWEEN IRON METABOLISM AND ETHANOL EFFECT ON CELL PROLIFERATION IN THE HUMAN HEPATOMA HEPARG CELL LINE
HIGHLY SENSITIVE HISTOCHEMICAL STAINING OF IRON COMBINED TO GENETIC ANALYSIS OF ARABIDOPSIS EMBRYOS REVEAL THAT IRON SPECIFICALLY ACCUMULATES IN THE ENDODERMAL CELL LAYER
CHARACTERIZATION OF FELINE SERUM FERRITIN-BINDING POTEINS: THE PRESENCE OF A NOVEL FERRITIN-BINDING PROTEIN AS AN INHIBITORY FACTOR IN FERRITIN IMMUNOASSAY
REGULATORY EFFECTS OF FERRITIN ON H-KININOGEN: IMPLICATIONS FOR ANGIOGENESIS
OVEREXPRESSION OF IRP2 INCREASES THE GROWTH OF TUMOR XENOGRAFTS IN NUDE MICE
C282Y AND H63D MUTATIONS IN HFE GENE IMPACT ON EPITHELIAL OVARIAN CANCER RISK AND SURVIVAL
GENOME-WIDE MICROARRAY ANALYSIS OF MELANOMA REVEALS UNEXPECTED ANOMALIES IN IRON-RELATED GENE EXPRESSION
A ROLE FOR LUMINAL IRON IN COLORECTAL CARCINOGENESIS
MOLECULAR-GENETIC ANALYSIS OF CERULOPLASMIN IN OESOPHAGEAL CANCER
MUTATION ANALYSIS OF THE SLC40A1 PROMOTER IN BLACK SOUTH AFRICAN OESOPHAGEAL CANCER PATIENTS
MOLECULAR CHARACTERIZATION OF THE 5′ UNTRANSLATED REGION (UTR) OF THE CYTOCHROME B REDUCTASE 1 (CYBRD1) GENE OF OESOPHAGEAL CANCER PATIENTS
HEPHAESTIN IS INVOLVED IN CONTROLLING IRON EFFLUX FROM OLIGODENDROCYTES IN THE CENTRAL NERVOUS SYSTEM
EXTRACELLULAR H-FERRITIN IS AN ALTERNATIVE IRON IMPORT MECHANISM IN OLIGODENDROCYTES, AND ITS RECEPTOR IS TIM-2
THE COMPARTAMENTALIZED DISTRIBUTION OF FERROPORTIN IN THE MOUSE CENTRAL NERVOUS SYSTEM IS INDICATIVE OF A DELICATE FUNCTION FOR NEURONAL IRON METABOLISM
IRON UPTAKE IN THE RETINA OF THE RAT: IMPLICATIONS FOR AGE-INDEPENT AND CONTINOUS IRON UPTAKE, PLUS ANTEROGRADE AXONAL IRON TRANSPORT BY RETINAL GANGLION CELLS
RELATIONSHIP BETWEEN BRAIN R2 AND LIVER AND SERUM IRON CONCENTRATIONS IN ELDERLY MEN
THE HEPCIDIN MRNA AND FPN1 PROTEIN EXPRESSION IN THE CP-/-MOUSE BRAIN
THE INCREASING IRON ACCUMULATION IN THE AGING BRAIN IS REFLECTED BY AN INCREASE IN NEURONAL FERRITIN RATHER THAN OF FERROPORTIN
INHIBITION OF PROLIFERATION OF OLN 93 CELLS BY IRON CHELATORS: USE AS TEST SYSTEM TO STUDY THE BIOAVAILABILITY OF IRON IN IRON OXIDE NANOPARTICLES
THE IONOTROPIC GLUTAMATE RECEPTOR AGONIST N-METHYL D-ASPARTATE (NMDA) AND SPATIAL MEMORY TRAINING ENHANCE THE EXPRESSION OF THE IRON TRANSPORTER DMT1 IN HIPPOCAMPAL NEURONS
BRAIN IRON MANAGEMENT PROTEIN GENE EXPRESSION VARIES ACROSS THE DIURNAL CYCLE AND WITH DIETARY IRON DEPRIVATION
GENOME-WIDE MICROARRAY ANALYSIS OF BRAIN FROM A HEMOCHROMATOSIS HFE KNOCKOUT MOUSE MODEL SHOWS FEW CHANGES IN IRON-RELATED GENE EXPRESSION
QUANTIFICATION OF IRON IN HUMAN BRAIN IN VIVO USING APPARENT TRANSVERSE RELAXATION RATE OBTAINED AT HIGH FIELD MRI
CHARACTERIZATION OF THE IRON MANAGEMENT PROTEIN PROFILES IN THE BRAINS OF MICE CARRYING THE H67D MUTATION IN HFE GENE
FORWARD GENETIC ANALYSIS OF BRAIN IRON MANAGEMENT DURING IRON DEFICIENCY
CELLULAR IMPACT OF H63D HFE MUTANT PROTEIN ON ALS
CERULOPLASMIN DIFFERENTIAL EXPRESSION IN THE CEREBROSPINAL FLUID OF PARKINSON'S DISEASE REFLECTS OXIDATION AND FUNCTIONAL IMPAIRMENT FAVOURING INTRACELLULAR IRON OVERLOAD
ASSOCIATION STUDIES IN ALZHEIMER'S DISEASE EXCLUDE CAT53 AS A NEW SUSCEPTIBILITY GENE BUT SUPPORT A PUTATIVE PROTECTIVE ROLE OF THE C282Y HFE MUTATION
HFE POLYMORPHISM, H63D, IMPACTS TAU PHOSPHORYLATION
REACTIVE OXYGEN SPECIES REGULATE CERULOPLASMIN BY A NOVEL MRNA DECAY MECHANISM INVOLVING ITS 3′-UNTRANSLATED REGION: IMPLICATIONS IN IRON DEPOSITION IN NEURODEGENERATIVE DISEASES
LONG TERM DEFERIPRONE INDUCES IRON DEFICIENCY IN FRIEDREICH ATAXIA PATIENTS
ABNORMAL METAL DISTRIBUTION IN THE WHITE MATTER OF THE BRAIN IN FRIEDREICH ATAXIA
THE EXPRESSION AND ROLE OF LIPOCALIN 2 AND ITS RECEPTOR AFTER SPINAL CORD INJURY
HO-1-MEDIATED MACROAUTOPHAGY: A MECHANISM FOR UNREGULATED BRAIN IRON DEPOSITION
GENE EXPRESSION CHANGES RELATED TO ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS IN A HEMOCHROMATOSIS HFE KNOCKOUT MOUSE MODEL
THE ROLE OF MITOCHONDRIAL FERRITIN ON HYDROGEN PEROXIDE INDUCED SH-SY5Y CELL DAMAGE
IRON, FRATAXIN AND FRIEDREICH'S ATAXIA NEURODEGENERATION: DEFECTIVE FOLDING AND FUNCTION IN COMPOUND HETEROZYGOTES
ANALYSIS OF IRON HOMEOSTASIS IN SKIN FIBROBLASTS FROM PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION PATIENTS
SYNCHROTRON X-RAY FLUORESCENCE REVEALS ABNORMAL DISTRIBUTION OF METALS IN BRAIN AND SPINAL CORD IN SPINOCEREBELLAR ATAXIA: A CASE REPORT
SERUM FERRITIN IS NOT RELATED TO COGNITIVE STATUS - RESULTS FROM A PERSPECTIVE COMMUNITY STUDY OF OLDER AUSTRALIANS
THE ROLE OF EXTERNAL LOOPS OF CERULOPLASMIN IN STABILIZING FERROPORTIN ON CELL MEMBRANE
CYSTEINE OXIDATION REGULATES THE RNA-BINDING ACTIVITY OF IRON REGULATORY PROTEIN 2 DURING OXIDATIVE STRESS
PROTECTION OF CARDIAC CELLS AGAINST OXIDATIVE INJURY BY NOVEL IRON CHELATORS - KETONE ANALOGS OF SALICYLALDEHYDE ISONICOTINOYL HYDRAZONE (SIH)
EFFECTS OF OXIDATIVE STRESS ON IRON REGULATORY GENES IN TWO DIFFERENT MICE MODELS FOR NAFLD
THE CRITICAL ROLE OF INTRACELLULAR LABILE IRON AND FERRITIN IN THE RESISTANCE OF CELLS TO HYDROGEN PEROXIDE
PROTECTION OF CARDIOMYOCYTES AGAINST CATECHOLAMINE INJURY BY IRON CHELATOR SALICYLALDEHYDE ISONICOTINOYL HYDRAZONE (SIH)
PARAQUAT DOWN-REGULATES IRON REGULATORY PROTEIN 1 ACTIVITIES AND EXPRESSION IN MURINE RAW 264.7 CELLS AND BONE MARROW-DERIVED MACROPHAGES
IRON METABOLISM UNDER DIQUAT-INDUCED OXIDATIVE STRESS IN FISCHER-344 RATS
HEMIN IS TOXIC TO ASTROCYTES: ARE IRON OR OXIDATIVE STRESS INVOLVED?
IRON CHELATION BY SYNTHETIC CHELATORS AND FLAVONOIDS DEPENDS ON PH
POLYANHYDROGLUCURONIC ACID DERIVATIVE OF LACTOFERRIN DOES NOT IMPROVE ITS PROTECTIVE EFFECTS ON CATECHOLAMINE CARDIOTOXICITY
IRONING OUT FRIEDREICH'S ATAXIA: THE MOLECULAR CHANGES BEHIND MITOCHONDRIAL IRON-LOADING AND EXPLORATION OF IRON-CHELATION THERAPY FOR TREATMENT
FURIN EXPRESSION IS DECREASED IN THE LIVER OF HFE-HEMOCHROMATOSIS PATIENTS
LIVER TRANSCRIPTOME OF THE F2 PROGENY OF B6 AND D2 HFE-DEFICIENT MICE: ROLE OF IRON LOADING AND GENETIC BACKGROUND.
INTERACTION OF DEFERASIROX (ICL670) WITH METAL IONS USED IN CONTRAST AGENTS
A NOVEL SIMULTANEOUS QUANTITATIVE METHOD FOR HEPCIDIN ISOFORMS USING LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY
CARDIAC GENE EXPRESSION IN MOUSE MODELS OF IRON LOADING DISORDERS
PROPERTIES OF THE METAL-ION TRANSPORTER ZIP14 SUGGEST A ROLE IN CELLULAR UPTAKE OF NONTRANSFERRIN-BOUND IRON (NTBI) CHARACTERISTIC OF IRON-OVERLOAD CONDITIONS
MORTALITY AMONG PATIENTS WITH PHENOTYPIC HEREDITARY HEMOCHROMATOSIS AND AMONG THEIR FAMILY MEMBERS: ARE FIRST-DEGREE RELATIVES AT INCREASED RISK?
BONE STATUS IN A MOUSE MODEL OF GENETIC HEMOCHROMATOSIS
COORDINATION CHEMISTRY OF TWO METABOLITES OF DEFERASIROX (ICL670) AND THE CRYSTAL STRUCTURE OF AN IRONDEFERASIROX-COMPLEX
MUTATION ANALYSIS OF GENES INVOLVED IN IRON REGULATION IN AN INDIAN FAMILY PRESENTING WITH IRON OVERLOAD
IRON ABSORPTION IN DYSMETABOLIC IRON OVERLOAD SYNDROME IS DECREASED CORRELATING WITH INCREASED PLASMA HEPCIDIN
MULTIPLE PREGNANCIES DO NOT REDUCE BODY IRON STORES IN THE HFE-/-MOUSE MODEL OF HEMOCHROMATOSIS
HAEMOCHROMATOSIS-ASSOCIATED GENES IN THE ZEBRAFISH
THE EFFECT OF DIETARY IRON ON TISSUE IRON LEVELS IN INTACT AND SPLENECTOMIZED MICE AFFECTED BY Beta-THALASSEMIA
SYNTHESIS AND COMPLEX FORMATION OF WATER SOLUBLE DERIVATIVES OF THE IRON-CHELATING LIGAND DEFERASIROX (ICL670)
DISTRIBUTION AND CHEMICAL SPECIATION OF IRON DEPOSITS IN HEARTS FROM TRANSFUSION DEPENDENT PATIENTS
MUTATION ANALYSIS OF HEPCIDIN AND FERROPORTIN GENES: POSSIBLE RELATIONSHIP WITH IRON OVERLOAD IN ITALIAN PROSPECTIVE BLOOD-DONORS
PRELIMINARY STUDY ON GENETIC MODIFIERS THAT MAY INFLUENCE THE IRON OVERLOAD IN SUBJECTS WITH H63D MUTATION
IRON-CHELATOR-THERAPY RESTORES MAJOR SYMPTOMS OF A FEMALE PATIENT SUFFERING FROM MICROCYTIC ANEMIA AND SEVERE IRON-OVERLOAD OF THE BONE-MARROW AND THE LIVER
IS IRON OVERLOAD IN ALCOHOL-RELATED CIRRHOSIS MEDIATED BY HEPCIDIN?
USEFULNESS OF MAGNETIC RESONANCE IMAGING FOR NON-INVASIVE TISSUE AND HISTOLOGICAL CHARACTERIZATION OF IRON OVERLOAD DEPOSITS IN MICE
THE EFFECT OF ACCESS TO NON-INVASIVE LIVER IRON CONCENTRATION MEASUREMENTS ON PATIENTS AT RISK OF IRON OVERLOAD FROM MULTIPLE BLOOD TRANSFUSIONS: AN AUDIT AND RETROSPECTIVE STUDY
LIVER IRON OVERLOAD IN NON HFE RELATED HYPERFERRITINEMIC PATIENTS
INTESTINAL IRON ABSORPTION DURING PHLEBOTOMY THERAPY IN PATIENTS AFFECTED BY HEMOCHROMATOSIS TYPE 1
ASSOCIATION BETWEEN HFE GENOTYPE AND IRON OVERLOAD IN PATIENTS WITH LIVER DISEASES FROM WESTERN ROMANIA
FREQUENCY OF C282Y AND H63D MUTATIONS OF THE HEMOCHROMATOSIS GENE IN A NORTHEASTERN BRAZILIAN POPULATION
IRON CHELATION IN PATIENTS WITH THALASSEMIA INTERMEDIA AND OTHER NON TRANSFUSION DEPENDENT CONGENITAL HEMOLYTIC ANEMIAS
HYPERFERRITINEMIA CATARACT SYNDROME, IS THERE A RENAL COMPONENT?
HEREDITARY HEMOCROMATOSIS AND DIABETES MELLITUS (DM), CAUSE OR COINCIDENCE? A NORTHEASTERN BRAZILIAN EXPERIENCE
PILOT PHARMACOKINETIC STUDY IN PATIENTS WITH INADEQUATE RESPONSE TO DEFERASIROX (EXJADE)
MITOCHONDRIAL DYSFUNCTION MAY EXPLAIN THE CARDIOMYOPATHY OF CHRONIC IRON OVERLOAD
THE IRON CHELATOR DEXRAZOXANE PROTECTS CARDIOMYOCYTES FROM DOXORUBICIN-MEDIATED CELL DEATH: ROLE OF HIF-1
INCREASED IRON ABSORPTION IS ASSOCIATED WITH UPREGULATION OF DUODENAL DMT1, DCYTB AND HEPHAESTIN EXPRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS
THE COMPARATIVE ANALYSES OF SINGLE NUCLEOTIDE POLYMORPHISM OF OXIDATIVE DNA REPAIR GENES IN PATIENTS WITH HCVRELATED LIVER DISEASE
THE CLINICAL AND GENETIC SPECTRUM OF TMPRSS6 MUTATIONS LEADING TO INAPPROPRIATE HEPCIDIN EXPRESSION AND IRON REFRACTORY IRON DEFICIENCY ANEMIA (IRIDA)
GENOME-WIDE ASSOCIATION STUDY OF IRON DEFICIENCY
IRON DEFICIENCY DETECTED BY ESTIMATION OF BODY IRON IN A PRIMARY CARE POPULATION: PREVALENCE AND ETIOLOGY
IRON UTILISATION FROM ORAL IRON TREATMENT IS DEPENDENTD FROM THE INDIVIDUAL BLEEDING RATE IN PATIENTS WITH HYPERMENORRHEA OR GASTROINTESTINAL HEMORRHAGE
THE MENKES COPPER ATPASE (ATP7A) GENE ENCODES TWO NUCLEAR PROTEIN VARIANTS THAT INTERACT WITH DNA AND ARE INDUCED DURING IRON DEFICIENCY
POTENTIAL ABNORMALITIES IN IRON PROCESSING BY MUCOLIPIDOSIS TYPE IV PATIENT FIBROBLASTS
ISOTHERMAL TITRATION CALORIMETRY OF HUMAN SERUM TRANSFERRIN INTERACTION WITH THE SOLUBLE PORTION OF THE RECEPTOR
“IN SILICO” MAPPING OF LIVER IRON LEVELS IN INBRED MICE
A HIGH PREVALENCE OF SUB-CLINICAL IRON DEFICIENCY IN BLOOD DONORS THAT PASSED THE SCREENING TEST FOR HEMOGLOBIN
ROLE OF IRON REPLACEMENT THERAPY IN THE ROUTINE MANAGEMENT OF BLOOD DONORS
VALIDATING A SELF-REPORTED PROTOCOL FOR MENSTRUAL BLOOD LOSS IN PATIENTS WITH IRON DEFICIENCY ANAEMIA
PREVALENCE AND TRANSFORMATION'S PROBABILITY OF IRON DEPLETION TO ANEMIA IN CHILDREN
HFE-RELATED HEMOCHROMATOSIS PHENOTYPIC SCREENING IN 53119 SUBJECTS: THE BRITTANY EXPERIENCE
CLINICAL EXPRESSION OF HFE-ASSOCIATED HAEMOCHROMATOSIS IN SUBJECTS UNDER 40 YEARS OF AGE
SCREENING FOR IRON OVERLOAD: LESSONS FROM THE HEIRS STUDY
HFE-C282Y HOMOZYGOTES WITH ELEVATED SF LESS THAN 1000 μG/L ARE NOT AT INCREASED RISK OF HAEMOCHROMATOSIS-ASSOCIATED DISEASE FEATURES
NOMOGRAM TO DETECT THE RISK FOR IRON OVERLOAD-ATTRIBUTED DISEASE IN SIBLINGS OF PROBANDS WITH HFE-RELATED SYMPTOMATIC HEMOCHROMATOSIS: RESULTS OF THE HEMOCHROMATOSIS FAMILY STUDY
HFE COMPOUND HETEROZYGOTES ARE AT LOW RISK OF HEMOCHROMATOSIS-RELATED MORBIDITY
JAPANESE PATIENTS WITH HEMOJUVELIN-HEMOCHROMATOSIS WHO SURVIVED OVER 50 YEARS
ADRENERGIC OVERDRIVE IN IRON OVERLOADED PATIENTS WITH HEMOCHROMATOSIS
EXTRINSIC FACTORS INFLUENCING THE EXPRESSIVITY OF THE HFE VARIANT C282Y, H63D, S65C PHENOTYPES IN DANISH MEN AGED 30-53 YEARS
DOES HLA-TYPE OR T-LYMPHOCYTE SUBSETS HAVE ANY RELEVANCE FOR PLANNING THE FOLLOWUP OF PERSONS WITH SCREENINGDETECTED HEMOCHROMATOSIS? PRELIMINARY DATA FROM NORTH TRØNDELAG COUNTY, NORWAY
SELDI-TOF MS DETECTION OF URINARY HEPCIDIN
PHENOTYPIC PENETRANCE OF THE HFE GENE C282Y, H63D AND S65C VARIANTS IN DANISH MEN AGED 30-53 YEARS
DELINEATING THE EXPERIENCES OF HEREDITARY HEMOCHROMATOSIS PATIENTS ALONG THE PATIENT PATHWAY: AN INTERNATIONAL QUANTITATIVE SURVEY OF 210 PATIENTS
A PORTUGUESE PATIENT HOMOZYGOUS FOR THE HAMP-25→ A MUTATION-30 YEARS FOLLOW UP
EVALUATION OF PATIENT SATISFACTION WITH PHLEBOTOMY FOR THE TREATMENT OF HEREDITARY HEMOCHROMATOSIS: AN INTERNATIONAL QUANTITATIVE SURVEY OF 210 PATIENTS
INFECTIOUS DISEASES IN DIAGNOSED PATIENTS OF GENETIC HEMOCHROMATOSIS
ARTERIAL HYPERTENSION IN PATIENTS WITH GENETIC HEMOCHROMATOSIS
SNPS ASSOCIATED WITH IRON INDICES IN A CANDIDATE GENE STUDY OF HEREDITARY HAEMOCHROMATOSIS
CELLULAR CHARACTERISATION OF MAMMALIAN MON1A: A PUTATIVE TRAFFICKING PROTEIN AND MODIFIER OF THE HAEMOCHROMATOSIS PHENOTYPE
HFE, SLC40A1, HAMP, HJV, TFR2, AND FTL MUTATONS DETECTED BY DENATURING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY AFTER IRON PHENOTYPING AND HFE C282Y AND H63D GENOTYPING IN 785 HEIRS STUDY PARTICIPANTS
MUTATION ANALYSIS OF SEVEN GENES INVOLVED IN IRON METABOLISM IN A MENNONITE POPULATION
SYNTHESIZING THE EVIDENCE FOR THE ASSOCIATION BETWEEN THE G277S SUBSTITUTION IN THE TRANSFERRIN GENE AND IRON DEFICIENCY BY COMBINING DATA FROM POPULATION STUDIES
CHANGES OF THE EXPRESSIONS OF THE GENES INVOLVED IN IRON METABOLISM BY THE IRON CHELATION THERAPY AND PHLEBOTOMY IN THE IRON OVERLOADED MOUSE MODEL
COMPARATIVE ABILITY OF IRON CHELATORS TO REMOVE IRON FROM ALBUMIN-IRON (III) COMPLEXES
H-FERRITIN SIRNA DELIVERED BY CATIONIC LIPOSOMES INCREASES GLIOMA CELL SENSITIVITY TO RADIATION AND CHEMOTHERAPEUTIC AGENTS
A COMPARATIVE STUDY OF THE ANTIPROLIFRATIVE ACTIVITY OF IRON CHELATORS PIH, SIH AND THEIR PHOTOLABILE CAGEDDERIVATIVES IN SKIN CELLS
L-TYPE CALCIUM CHANNEL BLOCKER, VERAPAMIL, IMPROVES SURVIVAL AND REDUCES IRON LOADING IN HYPOTRANSFERRINAEMIC MICE
IRON DEPLETION THERAPY FOR PATIENTS WITH METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE: PRELIMINARY FINDINGS
HIGH THROUGH-PUT SCREENING OF CHEMICALS THAT STIMULATE IRON UPTAKE - A NOVEL APPROACH TO DISCOVERY OF ANTICANCER DRUGS
FRIEDREICH'S ATAXIA: PROTEIN TRANSDUCTION OF TAT-CONJUGATED FRATAXIN MAY BE A NOVEL THERAPY
POTENT IRON CHELATORS AS ANTI-TUMOR AGENTS: THE NOVEL 2-ACETYLPYRIDINE THIOSEMICARBAZONE SERIES
FRATAXIN-EXPRESSION IS INCREASED BY RECOMBINANT HUMAN ERYTHROPOIETIN INDEPENDENT OF EXPRESSION OF THE CLASSICAL ERYTHROPOIETIN RECEPTOR
MOLECULAR IMPACT OF HUMAN DIVALENT METAL-ION TRANSPORTER-1 (DMT1) MUTATIONS ASSOCIATED WITH DISEASE PHENOTYPES
THE FIRST CELLULAR MODELS FOR FRIEDREICH ATAXIA BASED ON FRATAXIN MISSENSE MUTATIONS THAT REPRODUCE SPONTANEOUSLY FE-S CLUSTERS DEFECT AND INTRAMITOCHONDRIAL IRON DEPOSITS
RETROMER IS REQUIRED FOR PROPER ENDOSOMAL SORTING OF MAMMALIAN IRON TRANSPORTER, DMT1
EVENTS IN THE ENDOSOME LINK HEME AND IRON HOMEOSTASIS WITH THAT OF COPPER IN THE HEMOPEXIN SYSTEM
MECHANISMS UNDERLYING HEPATIC IRON ACCUMULATION IN A DIETARY EXPERIMENTAL MODEL OF NAFLD
HEPATIC IRON DEPOSITION IN RETICULOENDOTHELIAL CELLS BUT NOT HEPATOCYTES IS ASSOCIATED WITH MORE SEVERE NASH: RESULTS FROM THE NASH CLINICAL RESEARCH NETWORK
OSYSL15 IS AN IRON-REGULATED IRON (III)-PHYTOSIDEROPHORE TRANSPORTER AND IS ESSENTIAL FOR IRON UPTAKE IN RICE PLANTS
PORPHYRIN DISTORTION AND METAL ION SELECTIVITY IN FERROCHELATASE
SERUM FERRITIN AND HEPCIDIN LEVELS PREDICT VASCULAR DAMAGE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
RECOMBINANT HUMAN ERYTHROPOIETIN DOPING IN AN EXPERIMENTAL MODEL OF CHRONIC AEROBIC EXERCISE TRAINING
IRON UPTAKE BY CHROMERA VELIA
SMALL MOLECULE INHIBITORS OF HYPOXIA INDUCIBLE FACTOR 2A (HIF2A) TRANSLATION LINK ITS 5′-UNTRANSLATED REGION (5′-UTR) IRON RESPONSIVE ELEMENT (IRE) TO IRP-1 MEDIATED OXYGEN SENSING